[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK1224297T3 - Alzheimer's disease -secretase, APP substrates, and applications thereof - Google Patents

Alzheimer's disease -secretase, APP substrates, and applications thereof

Info

Publication number
DK1224297T3
DK1224297T3 DK00965338T DK00965338T DK1224297T3 DK 1224297 T3 DK1224297 T3 DK 1224297T3 DK 00965338 T DK00965338 T DK 00965338T DK 00965338 T DK00965338 T DK 00965338T DK 1224297 T3 DK1224297 T3 DK 1224297T3
Authority
DK
Denmark
Prior art keywords
secretase
alzheimer
disease
applications
app substrates
Prior art date
Application number
DK00965338T
Other languages
Danish (da)
Inventor
Mark Gurney
Michael Jerome Bienkowski
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1999/020881 external-priority patent/WO2000017369A2/en
Priority claimed from US09/416,901 external-priority patent/US6699671B1/en
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Application granted granted Critical
Publication of DK1224297T3 publication Critical patent/DK1224297T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6478—Aspartic endopeptidases (3.4.23)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96472—Aspartic endopeptidases (3.4.23)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK00965338T 1999-09-23 2000-09-22 Alzheimer's disease -secretase, APP substrates, and applications thereof DK1224297T3 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US15549399P 1999-09-23 1999-09-23
US40413399A 1999-09-23 1999-09-23
PCT/US1999/020881 WO2000017369A2 (en) 1998-09-24 1999-09-23 Alzheimer's disease secretase
US09/416,901 US6699671B1 (en) 1998-09-24 1999-10-13 Alzheimer's disease secretase, APP substrates therefor, and uses therefor
US16923299P 1999-12-06 1999-12-06
PCT/US2000/026080 WO2001023533A2 (en) 1999-09-23 2000-09-22 Alzheimer's disease secretase, app substrates therefor, and uses therefor

Publications (1)

Publication Number Publication Date
DK1224297T3 true DK1224297T3 (en) 2009-09-07

Family

ID=34753605

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00965338T DK1224297T3 (en) 1999-09-23 2000-09-22 Alzheimer's disease -secretase, APP substrates, and applications thereof

Country Status (12)

Country Link
EP (1) EP1224297B1 (en)
AR (1) AR025754A1 (en)
AT (1) ATE431419T1 (en)
AU (1) AU782312B2 (en)
CA (1) CA2397786A1 (en)
CO (1) CO5770112A1 (en)
DK (1) DK1224297T3 (en)
ES (1) ES2327312T3 (en)
PE (1) PE20010693A1 (en)
PT (1) PT1224297E (en)
TW (2) TW200745552A (en)
WO (1) WO2001023533A2 (en)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7115410B1 (en) 1999-02-10 2006-10-03 Elan Pharmaceuticals, Inc. β-secretase enzyme compositions and methods
US7456007B1 (en) 1998-12-31 2008-11-25 Elan Pharmaceuticals, Inc. β-secretase enzyme compositions and methods
JP4653318B2 (en) 1999-02-10 2011-03-16 エラン ファーマシューティカルズ，インコーポレイテッド β-secretase enzyme composition and method
WO2000058479A1 (en) 1999-03-26 2000-10-05 Amgen Inc. Beta secretase genes and polypeptides
CA2374610A1 (en) 1999-06-28 2001-01-04 Jordan J. N. Tang Catalytically active recombinant memapsin and methods of use thereof
US7514408B1 (en) 1999-12-02 2009-04-07 Elan Pharmaceuticals, Inc. β-secretase enzyme compositions and methods
US6737420B2 (en) 2000-03-23 2004-05-18 Elan Pharmaceuticals, Inc. Compounds to treat Alzheimer's disease
US6713276B2 (en) 2000-06-28 2004-03-30 Scios, Inc. Modulation of Aβ levels by β-secretase BACE2
PE20020276A1 (en) 2000-06-30 2002-04-06 Elan Pharm Inc SUBSTITUTE AMINE COMPOUNDS AS ß-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER
EP1666452A2 (en) 2000-06-30 2006-06-07 Elan Pharmaceuticals, Inc. Compounds to treat Alzheimer's disease
US7806980B2 (en) 2000-12-23 2010-10-05 Elan Pharmaceuticals, Inc. Method for crystallizing human beta secretase in complex with an inhibitor
US7601528B1 (en) 2000-12-23 2009-10-13 Elan Pharmaceuticals, Inc. Crystallization and structure determination of glycosylated human beta secretase, an enzyme implicated in alzheimer's disease
US7217556B1 (en) 2000-12-23 2007-05-15 Pfizer Inc Crystallization and structure determination of glycosylated human beta secretase, an enzyme implicated in Alzheimer's disease
US7384773B1 (en) 2001-05-10 2008-06-10 Pfizer Inc Crystal of HIV protease-cleaved human beta secretase and method for crystallization thereof
US7524668B1 (en) 2001-05-10 2009-04-28 Elan Pharmaceuticals, Inc. Crystal of human beta secretase having monoclinic space group symmetry C2 and methods for crystallization thereof
JP2004535421A (en) 2001-06-01 2004-11-25 イーラン ファーマスーティカルズ、インコーポレイテッド Hydroxyalkylamine
WO2002100818A2 (en) 2001-06-13 2002-12-19 Elan Pharmaceuticals, Inc. Aminediols as agents for the treatment of alzheimer's disease
WO2003006013A1 (en) 2001-07-10 2003-01-23 Elan Pharmaceuticals, Inc. Diaminediols for the treatment of alzheimer's disease
BR0211121A (en) 2001-07-10 2004-10-26 Elan Pharm Inc Compound, methods for treating or preventing disease and for making a compound, intermediate, and use of a compound or salt
AU2002345247A1 (en) * 2001-07-26 2003-02-17 Astex Technology Ltd Crystal structure of beta-site app cleaving enzyme (bace) and use thereof
US7186539B1 (en) 2001-08-31 2007-03-06 Pharmacia & Upjohn Company Method for refolding enzymes
EP1432674A2 (en) 2001-10-04 2004-06-30 Elan Pharmaceuticals, Inc. Hydroxypropylamines
AU2002359301B2 (en) 2001-10-23 2008-07-03 Comentis, Inc. Beta-secretase inhibitors and methods of use
US7045311B2 (en) 2001-10-25 2006-05-16 Monogram Biosciences, Inc. Whole cell assay systems for cell surface proteases
BR0214035A (en) 2001-11-08 2005-04-26 Elan Pharm Inc Compound
US7273743B2 (en) 2002-02-21 2007-09-25 Elan Pharmaceuticals, Inc. Modified BACE
US7262208B2 (en) 2002-04-30 2007-08-28 Elan Pharmaceuticals, Inc. Hydroxypropyl amides for the treatment of Alzheimer's disease
US7442537B1 (en) 2002-05-10 2008-10-28 Elan Pharmaceuticals, Inc. Crystals of unliganded beta secretase and/or beta secretase-like proteins and the use thereof
JP2004000060A (en) * 2002-05-31 2004-01-08 Otsuka Pharmaceut Co Ltd METHOD FOR SCREENING COMPOUND AFFECTING PRODUCTION OF AMYLOID beta
DOP2003000765A (en) 2002-11-27 2004-05-31 Elan Fharmaceuticals Inc SUBSTITUTED UREAS AND USEFUL CARBAMATES FOR THE TREATMENT OF ALZHEIMER'S DISEASE (SUBSTITUTED UREAS AND CARBAMATES USEFUL IN THE TREATMENT OF ALZHEIMER`S DISEASE
DOP2004000888A (en) 2003-04-21 2004-11-15 Elan Fharmaceuticals Inc BENZAMIDA 2-HYDROXI-3-DIAMINOALCANS (BENZAMIDE 2-HYDROXY-3-DIAMINOALKANES
WO2004099402A1 (en) 2003-05-02 2004-11-18 Elan Pharmaceuticals, Inc. Glycosylation variants of bace
US20050239836A1 (en) 2004-03-09 2005-10-27 Varghese John Substituted hydroxyethylamine aspartyl protease inhibitors
EP1773756A2 (en) 2004-07-09 2007-04-18 Elan Pharmaceuticals, Inc. Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors
WO2006081171A1 (en) 2005-01-24 2006-08-03 Amgen Inc. Humanized anti-amyloid antibody
WO2007047305A1 (en) 2005-10-12 2007-04-26 Elan Pharmaceuticals, Inc. Methods of treating amyloidosis using cyclopropyl derivative aspartyl protease inhibitors
TW200815349A (en) 2006-06-22 2008-04-01 Astrazeneca Ab New compounds
JP5450407B2 (en) 2007-07-06 2014-03-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Substituted amino-quinazolinones, drugs containing said compounds, their use and methods of manufacture
TW201020244A (en) 2008-11-14 2010-06-01 Astrazeneca Ab New compounds
EP2281824A1 (en) 2009-08-07 2011-02-09 Noscira, S.A. Furan-imidazolone derivatives, for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders
EP2643299B1 (en) 2010-11-22 2016-06-22 Noscira, S.A. Bipyridine sulfonamide derivatives for the treatment of neurodegenerative diseases or conditions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09178743A (en) * 1995-12-27 1997-07-11 Oriental Yeast Co Ltd Determinationof soluble app
EP0848062A3 (en) * 1996-12-14 2000-07-05 Smithkline Beecham Corporation Aspartic protease ASP1
AU1726199A (en) * 1997-12-31 1999-07-19 Chiron Corporation Metastatic cancer regulated gene
KR100866676B1 (en) * 1998-09-24 2008-11-11 파마시아 앤드 업존 캄파니 엘엘씨 Alzheimer's Disease Secretase

Also Published As

Publication number Publication date
ATE431419T1 (en) 2009-05-15
WO2001023533A2 (en) 2001-04-05
TWI294462B (en) 2008-03-11
EP1224297B1 (en) 2009-05-13
ES2327312T3 (en) 2009-10-28
CO5770112A1 (en) 2007-06-29
AR025754A1 (en) 2002-12-11
TW200745552A (en) 2007-12-16
PT1224297E (en) 2009-08-17
CA2397786A1 (en) 2001-04-05
AU782312B2 (en) 2005-07-21
PE20010693A1 (en) 2001-06-24
EP1224297A2 (en) 2002-07-24
WO2001023533A3 (en) 2002-05-10
AU7607100A (en) 2001-04-30

Similar Documents

Publication Publication Date Title
DK1224297T3 (en) Alzheimer's disease -secretase, APP substrates, and applications thereof
NO20016314D0 (en) Mixtures and Processes for Oilfield Applications
NO20025656L (en) Soluble CTLA4 Mutant Molecules and Applications thereof
IS6385A (en) New uses and new N-azabicyclo-amide derivatives
NO20012158D0 (en) Substituted 2-phenylbenzimidazoles, process for preparation and use thereof
DK1303272T3 (en) Benzothiazole derivatives for the treatment of Alzheimer's disease and Parkinson's disease
DE60039086D1 (en) Information processing apparatus
NO20022334L (en) New composition and application
NO20020307D0 (en) N- (indolecarbonyl) piperazine
DE69918627D1 (en) Flat processing
NO20033086D0 (en) Lineor block copolymer and process for preparing the same
DE60045666D1 (en) SEMICONDUCTOR ARRANGEMENT AND INFORMATION PROCESSING ARRANGEMENT
IS5942A (en) 3,3-barylpiperidine and 2,2-barylmorpholine derivatives
DK1187640T3 (en) Water-absorbing resin compound and processing
DK1202996T3 (en) Titanium compounds, manufacture and use thereof
NO20034827L (en) Processing aid and process for polymer processing
NO20030868L (en) N- (3,5-dichloro-2-methoxyphenyl) -4-methoxy-3-piperazin-1-yl-benzenesulfonamide
NO20001909D0 (en) Process and plant for the preparation of 1,2-dichloroethane
NO20022626L (en) 1,2-phenylenediboric acid reagents and complexes
DE60020904D1 (en) returner
DE50009171D1 (en) CO 2 - COMPRESSOR
DE50107204D1 (en) 8BETA-SUBSTITUTED-11BETA-PENTYL AND 11BETA-HEXYL-ESTRA-1,3,5 (10) -TRIENDERIVATE
DE60005362D1 (en) PROGRAM OVERVIEW PROCESSING
DE60318352D1 (en) Self-adjusting "winner-line-up" amplifier
FR2824956B1 (en) SECURE ANTENNA SUPPORT